Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Invested Capital (2020 - 2026)

RxSight filings provide 6 years of Invested Capital readings, the most recent being $275.7 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 1.98% to $275.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $275.7 million, a 1.98% decrease, with the full-year FY2025 number at $275.7 million, down 1.98% from a year prior.
  • Invested Capital hit $275.7 million in Q4 2025 for RxSight, roughly flat from $276.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $281.2 million in Q4 2024 to a low of -$301.9 million in Q1 2021.
  • Median Invested Capital over the past 5 years was $177.6 million (2021), compared with a mean of $158.1 million.
  • The widest YoY moves for Invested Capital: up 154.72% in 2022, down 28.64% in 2022.
  • RxSight's Invested Capital stood at $178.0 million in 2021, then fell by 26.93% to $130.1 million in 2022, then grew by 23.29% to $160.4 million in 2023, then soared by 75.38% to $281.2 million in 2024, then fell by 1.98% to $275.7 million in 2025.
  • The last three reported values for Invested Capital were $275.7 million (Q4 2025), $276.0 million (Q3 2025), and $278.0 million (Q2 2025) per Business Quant data.